# name
Ivermectin to reduce malaria transmission II. Considerations
                regarding clinical development pathway

# metadata.dc.description.abstract[].value
The development of ivermectin as a complementary vector control
                tool will require good quality evidence. This paper reviews the
                different eco-epidemiological contexts in which mass drug
                administration with ivermectin could be useful. Potential
                scenarios and pharmacological strategies are compared in order
                to help guide trial design. The rationale for a particular
                timing of an ivermectin-based tool and some potentially useful
                outcome measures are suggested.

# metadata.dc.source[].value
Articles publicats en revistes (ISGlobal)

# metadata.dc.title[].value
Ivermectin to reduce malaria transmission II. Considerations
                regarding clinical development pathway